Intravenous Recombinant Interferon-Beta versus Interferon-Alpha-2b and Ribavirin in Combination for Short-Term Treatment of Chronic Hepatitis C Patients Not Responding to Interferon-Alpha

References

• Davis GL, Lau JY, Lim HL. Therapy for chronic hepatitis C. Gastroenterol Clin North Am 1994;23:603–13.
   PubMedGoogle Scholar
• Reichard O, Andersson J, Schvarcz R, Weiland O. Ribavirin treatment for chronic hepatitis C. Lancet 1991;337:1056–61.
   Google Scholar
• Di Bisceglie A, Shindo M, Fong T-L, Fried MW, Swain MG, Bergasa NV, et al. A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 1992;16:649–54.
   PubMed Web of Science ®Google Scholar
• Camps J, Garcia N, Riezu-Boj JI, Civeira MP, Prieto J. Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon. J Hepatol 1993;19:408–12.
   Google Scholar
• Reichard O, Yun Z, Sonneborg A, Weiland O. Hepatitis C viral RNA titers in serum prior to, during and after oral treatment with ribavirin for chronic hepatitis C. J Med Virol 1993;41:99–102.
   PubMedGoogle Scholar
• Reichard O, Norkrans G, Fryden A, Braconier J-H, Sonneborg A, Weiland O, et al. Randomised, double-blind, placebocontrolled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. Lancet 1998;351: 83–7.
   Google Scholar
• McHutchinson JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485–92.
   PubMed Web of Science ®Google Scholar
• Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, et al. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998;339:1493–9.
   PubMed Web of Science ®Google Scholar
• Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, et al. Interferon alpha-2b and ribavirin in combination for chronic hepatitis C patients not responding to interferon alpha alone: an italian multicenter, randomized, controlled, clinical study. Am J Gastroenterol 1998;93:2445–51.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Kiyosawa K, Sodeyama T, Tanaka E. Comparative study of clinical, histological and immunological responses to interferon therapy in type non-A, non-B chronic hepatitis. Am J Gastroenterol 1990;85:24–9.
   PubMed Web of Science ®Google Scholar
• Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F, et al. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991;338:914–5.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, et al. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon beta. Hepatology 1993;18:1319–25.
   PubMedGoogle Scholar
• Takano S, Satomura Y, Omata M, Japan Acute Hepatitis Cooperative Study Group. Effect of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlleddose study. Gastroenterology 1994;107:805–11.
   Google Scholar
• Chemello L, Silvestri E, Cavalletto L, Bernardinello E, Pontisso P, Belussi F, et al. Pilot study on the efficacy of intravenous natural beta interferon therapy in Italian patients with chronic hepatitis C and relation to HCV genotype. Int Hepatol Commun 1995;3:237–43.
   Web of Science ®Google Scholar
• Mazzoran L, Grassi G, Giacca M, Gerini U, Baracetti S, Fanni-Canelles M, et al. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients withchronic hepatitis C unresponsive to alpha-interferon. Ital J Gastroenterol Hepatol 1997;29:338–42.
   Google Scholar
• Okamoto H, Okada S, Sugiyama Y, Yutsomoto S, Tanak T, Yoshizawa H, et al. The 5'terminal sequence of the hepatitis C virus genome. Jpn J Exp Med 1990;60:167–77.
   PubMedGoogle Scholar
• Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Feinstone SM, Cristiano K, et al. Decrease in hepatitis C virus RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1990;115:700–4.
   Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–9.
   PubMed Web of Science ®Google Scholar
• Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673–9.
   PubMed Web of Science ®Google Scholar
• Okamoto H, Tokita H, Sakamoto M, Horikita M, Iizuka H, Mishiro S. Characterization of the genomic sequence of the type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1994;75:629–35.
   PubMedGoogle Scholar
• Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431–5.
   PubMed Web of Science ®Google Scholar
• Armitage P, Berry G Statistical methods in medical research. 3rd ed. Oxford: Blackwell Scientific; 1994.
   Google Scholar
• Solko W, Schalm JT, Brouwer L, Chemello L, Alberti A, Bellobuono A, et al. Interferon-ribavirin combination therapy for chronic hepatitis C. Dig Dis Sci 1996;41:131S–4S.
   Google Scholar
• Maertens G, Stuyver L. Genotypes and genetic variation of hepatitis C virus. In: Harrison TJ, Zuckerman AJ, editors. The molecular medicine of viral hepatitis. New York: John Wiley & Sons Ltd; 1977. p. 226–7.
   Google Scholar
• Simmonds P. Clinical relevance of hepatitis C genotypes. Gut 1997;40:291–3.
   PubMed Web of Science ®Google Scholar
• Perez R, Pravia R, Artimez L, Giganto F, Rodriguez M, Lombrana JLS, et al. Clinical efficacy of intramuscular human interferon beta vs interferon alpha-2b for the treatment of chronic hepatitis C. J Viral Hepatitis 1995;2:103–6.
   PubMedGoogle Scholar
• Fesce E, Airoldi A, Mondazzi L, Maggi G, Gubertini G, Bernasconi G, et al. Intramuscolar beta interferon for chronic hepatitis C: is it worth trying? Ital J Gastroenterol Hepatol 1998; 30:185–8.
   PubMedGoogle Scholar